BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9654604)

  • 1. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia.
    Taylor RN; de Groot CJ; Cho YK; Lim KH
    Semin Reprod Endocrinol; 1998; 16(1):17-31. PubMed ID: 9654604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor.
    Hayman R; Brockelsby J; Kenny L; Baker P
    J Soc Gynecol Investig; 1999; 6(1):3-10. PubMed ID: 10065419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in preeclampsia.
    Roberts JM
    Semin Reprod Endocrinol; 1998; 16(1):5-15. PubMed ID: 9654603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia.
    Brockelsby J; Hayman R; Ahmed A; Warren A; Johnson I; Baker P
    Lab Invest; 1999 Sep; 79(9):1101-11. PubMed ID: 10496528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preeclampsia as a maternal vascular disease].
    Amash A; Huleihel M; Sheiner E; Sapir O; Holcberg G
    Harefuah; 2007 Sep; 146(9):707-12, 733. PubMed ID: 17969310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia.
    Baker PN; Krasnow J; Roberts JM; Yeo KT
    Obstet Gynecol; 1995 Nov; 86(5):815-21. PubMed ID: 7566855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.
    Ness RB; Sibai BM
    Am J Obstet Gynecol; 2006 Jul; 195(1):40-9. PubMed ID: 16813742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic endothelial cell markers in primary antiphospholipid syndrome.
    Williams FM; Parmar K; Hughes GR; Hunt BJ
    Thromb Haemost; 2000 Nov; 84(5):742-6. PubMed ID: 11127848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
    Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?
    Greer IA; Lyall F; Perera T; Boswell F; Macara LM
    Obstet Gynecol; 1994 Dec; 84(6):937-40. PubMed ID: 7526306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipids and vascular dysfunction in preeclampsia.
    Lorentzen B; Henriksen T
    Semin Reprod Endocrinol; 1998; 16(1):33-9. PubMed ID: 9654605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors and endothelial dysfunction.
    Bauters C; Six I; Meurice T; Van Belle E
    Drugs; 1999; 58 Spec No 1():11-5. PubMed ID: 10526953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension and pregnancy. Diagnosis, physiopathology and treatment].
    Fournier A; Fievet P; el Esper I; el Esper N; Vaillant P; Gondry J
    Schweiz Med Wochenschr; 1995 Nov; 125(47):2273-98. PubMed ID: 8539576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial dysfunction: role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system].
    Calicchio R; Buffat C; Vaiman D; Miralles F
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):215-20. PubMed ID: 23721989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology and clinical manifestations in pre-eclampsia].
    Haram K; Bjørge L; Guttu K
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1426-31. PubMed ID: 10851940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions.
    Hubel CA
    Semin Reprod Endocrinol; 1998; 16(1):75-92. PubMed ID: 9654610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and placental growth in normal and compromised pregnancies.
    Ong S; Lash G; Baker PN
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):969-80. PubMed ID: 11141344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neutrophil and preeclampsia.
    Clark P; Boswell F; Greer IA
    Semin Reprod Endocrinol; 1998; 16(1):57-64. PubMed ID: 9654608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.